HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,264,727 | -3.1% | 99,900 | 0.0% | 0.01% | 0.0% |
Q1 2024 | $8,526,465 | -0.2% | 99,900 | 0.0% | 0.01% | 0.0% |
Q4 2023 | $8,542,449 | -14.2% | 99,900 | -10.2% | 0.01% | -25.0% |
Q3 2023 | $9,961,296 | +6.6% | 111,200 | +1.3% | 0.01% | +33.3% |
Q2 2023 | $9,348,372 | +3.5% | 109,800 | +0.5% | 0.01% | 0.0% |
Q1 2023 | $9,036,300 | -7.3% | 109,200 | -11.9% | 0.01% | -14.3% |
Q4 2022 | $9,752,600 | +8.3% | 124,000 | +2.0% | 0.01% | +16.7% |
Q3 2022 | $9,002,000 | +14.3% | 121,600 | +0.7% | 0.01% | +20.0% |
Q2 2022 | $7,874,000 | +3.1% | 120,800 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $7,637,000 | +28.2% | 120,800 | +7.6% | 0.00% | 0.0% |
Q4 2021 | $5,956,000 | -24.9% | 112,300 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $7,927,000 | +6.2% | 112,300 | +0.3% | 0.01% | 0.0% |
Q2 2021 | $7,464,000 | -42.1% | 112,000 | -3.5% | 0.01% | -44.4% |
Q1 2021 | $12,888,000 | -5.3% | 116,100 | +1.3% | 0.01% | -10.0% |
Q4 2020 | $13,609,000 | +36.6% | 114,600 | +0.4% | 0.01% | +25.0% |
Q3 2020 | $9,964,000 | -0.9% | 114,200 | +1.7% | 0.01% | -11.1% |
Q2 2020 | $10,058,000 | +2.7% | 112,300 | +14.2% | 0.01% | -10.0% |
Q1 2020 | $9,797,000 | -12.3% | 98,300 | +1.1% | 0.01% | -9.1% |
Q4 2019 | $11,168,000 | -8.2% | 97,200 | +0.8% | 0.01% | -15.4% |
Q3 2019 | $12,160,000 | +6.5% | 96,400 | +1.6% | 0.01% | +8.3% |
Q2 2019 | $11,420,000 | +38.6% | 94,900 | +0.7% | 0.01% | +33.3% |
Q1 2019 | $8,241,000 | -9.9% | 94,200 | +3.1% | 0.01% | -25.0% |
Q4 2018 | $9,145,000 | -12.4% | 91,400 | +0.3% | 0.01% | 0.0% |
Q3 2018 | $10,438,000 | +25.0% | 91,100 | -2.1% | 0.01% | +20.0% |
Q2 2018 | $8,349,000 | +24.6% | 93,100 | +1.6% | 0.01% | +25.0% |
Q1 2018 | $6,701,000 | +28.8% | 91,600 | +2.2% | 0.01% | +33.3% |
Q4 2017 | $5,204,000 | +32.6% | 89,600 | +2.4% | 0.01% | +50.0% |
Q3 2017 | $3,926,000 | +13.6% | 87,500 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $3,455,000 | -0.4% | 87,500 | +2.3% | 0.00% | 0.0% |
Q1 2017 | $3,469,000 | +2.4% | 85,500 | +1.4% | 0.00% | -20.0% |
Q4 2016 | $3,389,000 | +15.1% | 84,300 | +3.7% | 0.01% | 0.0% |
Q3 2016 | $2,944,000 | +20.6% | 81,300 | -3.4% | 0.01% | +25.0% |
Q2 2016 | $2,441,000 | -13.4% | 84,200 | +0.8% | 0.00% | -20.0% |
Q1 2016 | $2,820,000 | +28.2% | 83,500 | +22.4% | 0.01% | 0.0% |
Q4 2015 | $2,199,000 | -0.2% | 68,200 | 0.0% | 0.01% | -16.7% |
Q3 2015 | $2,204,000 | -10.3% | 68,200 | +14.8% | 0.01% | 0.0% |
Q2 2015 | $2,457,000 | -6.8% | 59,400 | +1.2% | 0.01% | -14.3% |
Q1 2015 | $2,637,000 | +22.1% | 58,700 | +1.7% | 0.01% | -12.5% |
Q4 2014 | $2,159,000 | +8.5% | 57,700 | +1.2% | 0.01% | 0.0% |
Q3 2014 | $1,990,000 | -2.4% | 57,000 | -1.4% | 0.01% | 0.0% |
Q2 2014 | $2,039,000 | +8.2% | 57,800 | 0.0% | 0.01% | +14.3% |
Q1 2014 | $1,884,000 | -0.6% | 57,800 | +28.4% | 0.01% | 0.0% |
Q4 2013 | $1,896,000 | +6.8% | 45,000 | +1.1% | 0.01% | 0.0% |
Q3 2013 | $1,775,000 | -9.3% | 44,500 | -5.9% | 0.01% | -22.2% |
Q2 2013 | $1,956,000 | – | 47,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |